Elisabeth Rowold Email

Clinical Project Manager . Dermaliq Therapeutics

Current Roles

Employees:
7
Revenue:
$703.5k
About
Dermaliq is developing the next generation of skin care therapies to enhance targeted penetration into skin tissues and to reduce unwanted side effects for millions of patients. The unique and proprietary technology owned by Dermaliq, called hyliQTM, is designed to allow cutaneous drug delivery with unmatched bioavailability. The technology enables the development of superior, highly effective liquid drug products with exceptional cosmetic properties.
Dermaliq Therapeutics Address
Corporation Trust Center 1209, Orange St
Wilmington, DE
Dermaliq Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.